Search results
Found 41389 matches for
The APPG on Malaria & NTDs gathered on Tuesday, March 19th in Westminster at the Houses of Parliament.
Unlocking the potential of genetic data for research and healthcare
5 June 2025
Researchers at the Big Data Institute have announced a new data format designed to unlock the potential of the millions of genomes now sequenced in global healthcare systems.
PSI publish first validated tool to measure stigma during disease outbreaks
4 June 2025
Researchers at the Pandemic Sciences Institute have published RAPID Stigma Scales to help health professionals monitor stigma in disease outbreak settings, improving outbreak responses globally.
CBF’s Omar El Muhanna awarded Jordanian Order for Distinction
30 May 2025
As part of the Hashemite Kingdom of Jordan’s 79th Independence Day celebrations on 25 May, His Majesty King Abdullah II bestowed the King Abdullah II Ibn Al Hussein Order for Distinction upon Omar El Muhanna, Senior Operations and Strategy Executive at NDM’s Clinical BioManufacturing Facility.
New method reveals access to proteins in ancient human remains
29 May 2025
A new method, developed by researchers at the Nuffield Department of Medicine, could soon unlock the vast repository of biological information held in the proteins of ancient soft tissues. The findings, which could open up a new era for palaeobiological discovery, have been published in PLOS ONE.
Project to develop low-cost genome sequencing for pathogens launched
28 May 2025
A low-cost genome sequencing technique that was used by thousands of laboratories globally to spot COVID-19 variants will be extended to cover all pathogens, in an ambitious new Wellcome Trust-funded project launched today. The ARTIC-2 project is led by the University of Birmingham and brings together researchers from the Democratic Republic of Congo, Ghana and Kenya with expertise in responding to numerous viral threats using genomic surveillance, including recent outbreaks of Ebola virus and Mpox in Africa.
Molecule enabling new leukaemia treatments discovered
20 May 2025
Researchers at the Shi Lab have discovered a first-in-class LSD1 PROTAC degrader, which opens up new therapeutic paths for the treatment of acute myeloid leukaemia. PROTAC degraders are molecules that degrade proteins by using the cell’s own machinery, binding to both the target protein and an E3 ligase, which marks it for degradation by the proteasome.
Eight NDM researchers awarded Associate Professorships
19 May 2025
We are delighted to announce that eight researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
Oxford and Thai health officials sign agreement on infectious disease control
15 May 2025
Representatives from the University of Oxford and the Tak Provincial Public Health Office signed a Memorandum of Understanding (MoU) to strengthen collaboration on infectious disease prevention and control along the Thai–Myanmar border. The agreement focuses on joint research into key diseases affecting the border population.
T cell responses to monkeypox play a part in protecting against infection
13 May 2025
A new study, led by researchers at the NDM's CAMS Oxford Institute and the Centre for Human Genetics, TIDU in the MRC Weatherall Institute of Molecular Medicine, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.
More effective and affordable treatment strategies for Hepatitis C
12 May 2025
NDM's Oxford University Clinical Research Unit (OUCRU) announced promising results from the VIETNARMS trial, a years-long multi-arm clinical trial conducted in Vietnam. The trial found that the readily available and affordable Hepatitis C treatment sofosbuvir/daclatasvir had a >95% cure rate. The results offer important insights into new treatment regimens for Hepatitis C, potentially reducing treatment durations and halving treatment costs.
Professor Yang Shi wins 2025 Léopold Griffuel Prize
8 May 2025
The ARC Foundation for Cancer Research has recognised Professor Yang Shi’s contributions to the field of cancer epigenetics with the 2025 Léopold Griffuel Prize for Fundamental Research.
Coeliac disease may be driven by immune structures in the gut
7 May 2025
Researchers in the Nuffield Department of Medicine have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease. These findings could provide a target for future therapies.
Professor Andrew McMichael elected to the US National Academy of Sciences
6 May 2025
The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
New guidelines published for monitoring IBD patients to prevent bowel cancer
2 May 2025
Led by NDM’s Professor James East, researchers and clinicians have developed major new guidelines for monitoring patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Common virus may improve skin cancer treatment outcomes
1 May 2025
May is Skin Cancer Awareness Month, and a new study with input from researchers in NDM’s units has revealed that a common virus may positively influence how skin cancer patients respond to current treatments.
New study confirms malaria drug safe for children and reduces disease burden
30 April 2025
A major study in The Lancet Infectious Diseases confirms that single low-dose primaquine is safe and effective in reducing malaria transmission in young children. Analysing data from over 6,000 patients, researchers found it effective even in young children and areas with high malaria burden.
Blog: Building better vaccines in Thailand
29 April 2025
Years of groundwork have led Assistant Professor Dr Thitinan Kitisin to his first major step: leading an advanced vaccine research project in Thailand. With support from MODRA, he’s now developing one of the first tonsil organoid models in the country, a small but important step toward improving how vaccines are tested. Along the way, he’s also passing on practical research skills to the next generation of Thai scientists.
Celebrating 10 years of the MSc in International Health and Tropical Medicine
28 April 2025
NDM's MSc in International Health and Tropical Medicine (IHTM) celebrated its tenth anniversary as an internationally renowned programme for future global health leaders, with over 100 alumni travelling from around the world to join colleagues, current students and guests in Oxford.
Study finds that Treg depletion suppresses tumour growth
24 April 2025
A new study, co-lead by Dr Felipe Galvez-Cancino from the Centre for Immuno-Oncology, has shown that Treg cell depletion can suppress tumour growth in one of the deadliest types of cancer.
Sarah Gilbert receives Royal Society of Chemistry Honorary Fellowship
23 April 2025
PSI Principal Investigator Professor Dame Sarah Gilbert has been made an Honorary Fellow of the Royal Society of Chemistry.